BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15517911)

  • 1. Absence of ras-gene hot-spot mutations in canine fibrosarcomas and melanomas.
    Murua Escobar H; Günther K; Richter A; Soller JT; Winkler S; Nolte I; Bullerdiek J
    Anticancer Res; 2004; 24(5A):3027-8. PubMed ID: 15517911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAS gene hot-spot mutations in canine neoplasias.
    Richter A; Murua Escobar H; Günther K; Soller JT; Winkler S; Nolte I; Bullerdiek J
    J Hered; 2005; 96(7):764-5. PubMed ID: 16251512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
    Kumar R; Angelini S; Hemminki K
    Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of ras genes in the neoplasmic transformation in animals.
    Rotkiewicz T; Słodki S; Otrocka-Domagała I
    Pol J Vet Sci; 2004; 7(1):47-52. PubMed ID: 15061485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of ras proto-oncogene mutations in selected mammalian tumors.
    Watzinger F; Mayr B; Gamerith R; Vetter C; Lion T
    Mol Carcinog; 2001 Apr; 30(4):190-8. PubMed ID: 11346881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
    Demunter A; Ahmadian MR; Libbrecht L; Stas M; Baens M; Scheffzek K; Degreef H; De Wolf-Peeters C; van Den Oord JJ
    Cancer Res; 2001 Jun; 61(12):4916-22. PubMed ID: 11406571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide sequence of canine c-N-ras: codons 1 to 71.
    Saunders KA; Madewell BR; Oreffo VI; Kraegel SA; Gumerlock PH
    Am J Vet Res; 1992 Apr; 53(4):600-3. PubMed ID: 1586036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.
    van Elsas A; Zerp SF; van der Flier S; Krüse KM; Aarnoudse C; Hayward NK; Ruiter DJ; Schrier PI
    Am J Pathol; 1996 Sep; 149(3):883-93. PubMed ID: 8780392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-ras mutation in a canine lymphoma: short communication.
    Mayr B; Holzheu M; Schaffner G; Reifinger M
    Acta Vet Hung; 2003; 51(1):91-4. PubMed ID: 12688129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-ras mutations in canine malignant melanomas.
    Mayr B; Schaffner G; Reifinger M; Zwetkoff S; Prodinger B
    Vet J; 2003 Mar; 165(2):169-71. PubMed ID: 12573607
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia.
    Detorakis ET; Zafiropoulos A; Arvanitis DA; Spandidos DA
    Eye (Lond); 2005 Feb; 19(2):210-4. PubMed ID: 15232598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAS, FLT3, and C-KIT mutations in immunophenotyped canine leukemias.
    Usher SG; Radford AD; Villiers EJ; Blackwood L
    Exp Hematol; 2009 Jan; 37(1):65-77. PubMed ID: 18977066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in tumour suppressor gene p53 in two feline fibrosarcomas.
    Mayr B; Schaffner G; Kurzbauer R; Schneider A; Reifinger M; Loupal G
    Br Vet J; 1995; 151(6):707-13. PubMed ID: 8605583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-ras mutation in a feline lymphoma. Low frequency of N-ras mutations in a series of feline, canine and bovine lymphomas.
    Mayr B; Winkler G; Schaffner G; Reifinger M; Brem G
    Vet J; 2002 May; 163(3):326-8. PubMed ID: 12090776
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2.
    Quintin-Colonna F; Devauchelle P; Fradelizi D; Mourot B; Faure T; Kourilsky P; Roth C; Mehtali M
    Gene Ther; 1996 Dec; 3(12):1104-12. PubMed ID: 8986437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple polymerase chain reaction markers for the differentiation of canine cutaneous peripheral nerve sheath tumours versus canine fibrosarcomas.
    Meyer A; Klopfleisch R
    J Comp Pathol; 2014; 150(2-3):198-203. PubMed ID: 24650889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of RAS gene family in specimens of bladder cancer.
    Karimianpour N; Mousavi-Shafaei P; Ziaee AA; Akbari MT; Pourmand G; Abedi A; Ahmadi A; Afshin Alavi H
    Urol J; 2008; 5(4):237-42. PubMed ID: 19101897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.
    Poehlmann A; Kuester D; Meyer F; Lippert H; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2007; 203(7):489-97. PubMed ID: 17629419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical diagnosis of skin tumours of the dog with special reference to undifferentiated types.
    Rabanal RH; Fondevila DM; Montané V; Domingo M; Ferrer L
    Res Vet Sci; 1989 Jul; 47(1):129-33. PubMed ID: 2475897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.